SNZZFSenzime AB

About Senzime AB (SNZZF)

Senzime AB (SNZZF) is a Medical Devices company headquartered in Uppsala, Sweden whose shares trade over-the-counter on the OTCQX tier.

Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world without anesthesia- and respiratory-related complications. The company markets an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for real-time monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures

Products and services

Senzime is a Swedish medical device company that develops, manufactures, and markets CE- and FDA-cleared patient monitoring systems. Senzime’s employees worldwide are committed to the vision of a world without anesthesia- and respiratory-related complications. The company markets an innovative portfolio of solutions, including the TetraGraph® and ExSpiron® 2Xi for real-time monitoring of neuromuscular and respiratory functions, typically under and after surgery. The goal is to help eliminate in-hospital complications, and radically reduce health care costs related to surgical and high acuity procedures. Senzime targets a market opportunity valued more than SEK 40 billion per year, and operates with sales teams in the world’s leading markets. The company’s shares are listed on Nasdaq Stockholm Main Market (SEZI). More information is available at senzime.com.

SNZZF key facts

Ticker symbol

SNZZF

Market tier

OTCQX

Sector

Healthcare

Industry

Medical Devices

Headquarters

Uppsala, Sweden

Country of incorporation

SE

Year of incorporation

1999

Employees

50

Estimated market cap

$71.91M (as of May 8, 2025)

Shares outstanding

133,174,523

Reporting standard

International Reporting: NASDAQ Stockholm

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Mar 31, 2025)

Senzime AB leadership

• Philip Siberg — CEO
• Slavoljub Grujicic — CFO
• Anders Jacobson — CIO

Explore more: Medical Devices stocks · Healthcare sector · OTCQX stocks · OTC stocks starting with S